Back

Metastability as a neuromechanistic biomarker of schizophrenia pathology

Hancock, F.; Rosas, F.; McCutcheon, R. A.; Cabral, J.; Dipasquale, O.; Turkheimer, F. E.

2022-10-17 psychiatry and clinical psychology
10.1101/2022.10.14.22281093 medRxiv
Show abstract

The disconnection hypothesis of schizophrenia proposes that symptoms of the disorder arise as a result of aberrant functional integration between segregated areas of the brain. The concept of metastability characterizes the coexistence of competing tendencies for functional integration and functional segregation in the brain and is therefore well suited for the study of schizophrenia. In this study we investigate metastability as a neuromechanistic biomarker of schizophrenia pathology, including a demonstration of reliability and face validity. Group-level discrimination, individual-level classification, and pathophysiological relevance were assessed using two independent case-control studies of schizophrenia, the Human Connectome Project Early Psychosis (HCPEP) study (controls n=82, non-affective psychosis n=53) and the Cobre study (controls n=71, cases n=59). In this work we introduce a new framework that uses Leading Eigenvector Dynamic Analysis (LEiDA) to capture specific features of dynamic functional connectivity and then implements a novel approach to estimate metastability. We used non-parametric testing to evaluate group-level differences and a naive Bayes classifier to discriminate cases from controls. Our results show that our new approach is capable of discriminating cases from controls with elevated effect sizes relative to published literature, reflected in an up to 76% area under the curve (AUC) in out-of-sample classification analyses. Furthermore, our analyses demonstrated that patients with early psychosis exhibit intermittent disconnectivity of subcortical regions with frontal cortex and cerebellar regions, introducing new insights about the mechanistic bases of these conditions. Overall, these findings demonstrate reliability and face validity of metastability as a neuromechanistic biomarker of schizophrenia pathology.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Human Brain Mapping
329 papers in training set
Top 0.6%
9.3%
2
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
71 papers in training set
Top 0.1%
8.5%
3
NeuroImage
903 papers in training set
Top 2%
6.0%
4
Molecular Psychiatry
282 papers in training set
Top 1%
5.2%
5
Frontiers in Neuroimaging
11 papers in training set
Top 0.1%
5.2%
6
Schizophrenia
21 papers in training set
Top 0.1%
4.9%
7
Biological Psychiatry
137 papers in training set
Top 0.7%
4.6%
8
NeuroImage: Clinical
144 papers in training set
Top 0.6%
4.6%
9
Nature Mental Health
21 papers in training set
Top 0.1%
4.2%
50% of probability mass above
10
PLOS ONE
5266 papers in training set
Top 33%
4.2%
11
PLOS Computational Biology
1863 papers in training set
Top 9%
3.8%
12
Translational Psychiatry
260 papers in training set
Top 2%
3.3%
13
Nature Communications
5641 papers in training set
Top 37%
3.1%
14
eLife
5828 papers in training set
Top 37%
3.1%
15
Communications Biology
993 papers in training set
Top 8%
2.5%
16
Scientific Reports
3612 papers in training set
Top 45%
2.3%
17
Schizophrenia Bulletin
32 papers in training set
Top 0.2%
2.3%
18
Frontiers in Psychiatry
87 papers in training set
Top 1.0%
2.3%
19
Imaging Neuroscience
282 papers in training set
Top 3%
2.0%
20
Neuropsychopharmacology
153 papers in training set
Top 2%
1.6%
21
Psychiatry and Clinical Neurosciences
11 papers in training set
Top 0.1%
1.4%
22
Cerebral Cortex
396 papers in training set
Top 4%
0.9%
23
Brain Communications
166 papers in training set
Top 3%
0.9%
24
Advanced Science
286 papers in training set
Top 10%
0.8%
25
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 43%
0.8%
26
Biological Psychiatry Global Open Science
60 papers in training set
Top 2%
0.6%
27
Network Neuroscience
126 papers in training set
Top 2%
0.6%